Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lumen Meds vs Spry

Lumen Meds
Graded #244

Higher grade

vs+7.6000000000000085
Spry
Graded #409

Lower grade

The verdict

Lumen Meds takes it — 64.4/100 to 56.8/100.

Lumen Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lumen Meds (lumenmeds.com) is a Delaware-incorporated compounded GLP-1 telehealth platform (Lumen Meds LLC, 128 Sunset Blvd #1214, New Castle, DE 19720).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLumen Meds +6
60
54
Dose & formulationSpry +12
52
64
Clinical oversightLumen Meds +21
76
55
Labs & monitoringLumen Meds +21
73
52
FulfillmentLumen Meds +9
70
61
Contract termsEven
55
55
Lumen Meds · left barSpry · right bar

The numbers

MetricLumen MedsSpry
WeighScore64.4/10056.8/100
GradeCC
Scorecard rank#244#409
SemaglutideNot disclosed$199/mo (starting dose, compounded)
Tirzepatide$196/mo (compounded)$299/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Lumen Meds

Graded #244 · C

Strengths

  • LegitScript Certified
  • Free expedited cold shipping — important for GLP-1 cold-chain integrity
  • Lifestyle coaching included, not just medication dispensing
  • Orders labs when needed
  • Named legal entity (Lumen Meds LLC, Delaware) with a physical address

Where it loses points

  • $0 first-month promo — verify recurring billing and cancellation terms before committing
  • Standard ongoing semaglutide price not shown (only the first-month promo)
  • Per-state availability not listed
  • Pharmacy partners not named
  • Health quiz required before you see final per-patient pricing
Spry

Graded #409 · C

Strengths

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

Where it loses points

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard